Startups & VC
Ray Therapeutics Series B: $125 Million
Vision restoration biotech Ray Therapeutics closed a $125 million Series B led by Janus Henderson on the 21st. Cumulative funding reaches $247 million.
Primary sources · 1
Vision restoration biotech Ray Therapeutics closed a $125 million Series B led by Janus Henderson on the 21st. Cumulative funding reaches $247 million.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.